Rhinomed Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
210.90
432.50
1,012.40
1,717.20
2,169.20
Cost of Goods Sold (COGS) incl. D&A
418.00
1,841.40
2,695.50
3,057.10
2,483.00
Gross Income
207.20
1,409.00
1,683.00
1,339.90
313.90
SG&A Expense
4,021.00
4,416.30
4,019.80
2,975.00
3,351.20
EBIT
4,228.10
5,866.90
5,704.40
4,314.90
3,665.10
Unusual Expense
225.00
80.80
25.00
-
-
Non Operating Income/Expense
49.00
5.60
730.20
542.60
427.70
Interest Expense
0.00
-
-
-
-
Pretax Income
3,923.00
5,887.30
6,436.00
4,832.50
4,079.70
Income Tax
388.40
570.30
437.50
390.90
75.40
Consolidated Net Income
3,534.60
5,317.00
5,998.50
4,441.60
4,004.30
Net Income
3,534.60
5,317.00
5,998.50
4,441.60
4,004.30
Net Income After Extraordinaries
3,534.60
5,317.00
5,998.50
4,441.60
4,004.30
Net Income Available to Common
3,534.60
5,317.00
5,998.50
4,441.60
4,004.30
EPS (Basic)
0.10
0.11
0.09
0.07
0.04
Basic Shares Outstanding
34,877.40
47,481.40
63,638.90
67,223.70
-
EPS (Diluted)
0.10
0.11
0.09
0.07
-
Diluted Shares Outstanding
34,877.40
47,481.40
63,638.90
67,223.70
-
EBITDA
3,987.50
5,415.90
5,177.10
3,844.70
3,293.00
Other Operating Expense
-
41.60
1.60
-
-
Non-Operating Interest Income
31.20
54.90
23.60
25.10
13.10
About Rhinomed
View Profile
